Falmer, United Kingdom

Tristan Reuillon


 


Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Sussex, GB (2021)
  • Falmer, GB (2022)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Tristan Reuillon: Pioneering AMPA Receptor Modulation

Introduction

Tristan Reuillon is a notable inventor based in Falmer, GB, recognized for his contributions to the field of pharmaceuticals, particularly in compounds that modulate AMPA receptor function. With a total of three patents to his name, Reuillon's work focuses on the development of innovative solutions for treating central nervous system disorders.

Latest Patents

Reuillon's most recent patents revolve around compounds designed to enhance AMPA receptor function. His patents detail the formula of the compounds, wherein distinct components are identified for use in pharmaceutical compositions. The compounds have been found to potentiate AMPA receptor function, showing promise in treating various conditions, including depressive and mood disorders, as well as cognitive dysfunction associated with neuropsychiatric disorders like schizophrenia. This important work highlights the potential for significant advancements in medical treatments derived from his inventions.

Career Highlights

Tristan Reuillon is affiliated with University College Cardiff Consultants Limited, where he continues to engage in impactful research and development. His dedication to innovating within the field of neuroscience positions him as a key figure in advancing therapeutic options for patients with complex psychological conditions. His research emphasizes a commitment to improving emotional and cognitive health through innovative medicinal strategies.

Collaborations

In his professional endeavors, Reuillon collaborates with distinguished colleagues such as Simon Ward and Paul John Beswick. Together, they contribute to a rich exchange of ideas and expertise within the research community, fostering an environment of innovation and discovery. These collaborations have undoubtedly played a vital role in the success of his inventions and their applications.

Conclusion

Tristan Reuillon's inventions in AMPA receptor modulation are not only groundbreaking but also hold the potential to transform the therapeutic landscape for various neuropsychiatric conditions. His work exemplifies the vital role of inventors in driving progress in medicine, showcasing how innovative research can lead to significant improvements in patient care and treatment outcomes. As Reuillon continues his endeavors at University College Cardiff Consultants Limited, the impact of his contributions will likely resonate within the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…